| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Common Stock | Sale | $1,058,714 | -9,955 | -2.2% | $106.35 | 440,264 | 01 Nov 2024 | Direct | F1, F2 |
| transaction | PCVX | Common Stock | Sale | $355,507 | -3,312 | -0.75% | $107.34 | 436,952 | 01 Nov 2024 | Direct | F1, F3 |
| transaction | PCVX | Common Stock | Sale | $188,030 | -1,733 | -0.4% | $108.50 | 435,219 | 01 Nov 2024 | Direct | F1, F4 |
| holding | PCVX | Common Stock | 138,581 | 01 Nov 2024 | By Children's Trust | F5 | |||||
| holding | PCVX | Common Stock | 138,581 | 01 Nov 2024 | By Children's Trust | F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024. |
| F2 | The price reported is a weighted-average price. The shares were sold at prices ranging from $105.855 to $106.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The price reported is a weighted-average price. The shares were sold at prices ranging from $106.865 to $107.845. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | The price reported is a weighted-average price. The shares were sold at prices ranging from $107.97 to $108.93. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| F6 | Shares are held directly by a trust for the benefit of the Reporting Person's son. |